valerates has been researched along with Broad Beta Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houlston, R; Lewis, B; Quiney, J; Watts, GF | 1 |
| Dodge, HT; Kostis, JB; Kuo, PT; Moreyra, AB; Wilson, AC | 1 |
| Breslow, JL; Eisenberg, S; Weintraub, MS | 1 |
3 other study(ies) available for valerates and Broad Beta Disease
| Article | Year |
|---|---|
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Male; Pentanoic Acids; Triglycerides; Valerates | 1988 |
Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery disease.
Topics: Adult; Combined Modality Therapy; Coronary Disease; Drug Evaluation; Exercise Test; Female; Gemfibrozil; Hand Dermatoses; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Valerates; Xanthomatosis | 1988 |
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
Topics: Cholestyramine Resin; Chylomicrons; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Pentanoic Acids; Triglycerides; Valerates; Vitamin A | 1987 |